The orthopaedic diagnostics equipment developer has added $18.5m to a series C round featuring Smith & Nephew that now stands at $37.6m.

The respiratory disease drug developer has collected series A funding from investors including Shionogi to fund clinical trials of its lead drug candidate .

Plant sciences startups Heliponix and Karyosoft each secured $50,000 investments after winning the fifth cohort of Purdue’s Ag-celerator competition.

Novo-backed Cirius Therapeutics, which was supported at launch by Metabolic Solutions Development Company, will put the IPO proceeds into its lead liver disease treatment.

NM Future Ventures alumni Alexa von Tobel and Mark Batsiyan have launched Inspired Capital, a venture capital firm aiming to raise $200m for its debut fund.

Chalmers Ventures has invested more funding in human resources app developer Winningtemp, which is preparing its employee wellbeing software for international expansion.

New York University has teamed up with corporate-backed biopharmaceutical incubator Futurx to spawn neurodegenerative disease drug developer Glixogen Therapeutics.

P&E Directions has joined existing investor Mitsui in a $12.4m round that increased the immunotherapy developer's total funding to more than $37m.

Toronto’s AmacaThera is preparing clinical trials of a drug delivery hydrogel that could diminish the need for prescription opioid painkillers after surgery.

Strathclyde-founded dermatological device manufacturer Cutitronics has collected further investment from specialty chemicals supplier Croda as the pair aim to win business with personal care brands.